Reported Earlier, Zentalis Pharmaceuticals Prices Underwritten Public Offering Of 23M Shares At $3.50 Per Share, Expects $80.5M Gross Proceeds
Share
Why It Matters
Zentalis is raising money by selling 23 million shares at $3.50 each, which will give them about $80.5 million to use for their business. When a company does this, watch whether they use the money wisely and whether existing owners feel the deal is fair.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.